T
Tal Brosh-Nissimov
Researcher at Medical Corps
Publications - 32
Citations - 984
Tal Brosh-Nissimov is an academic researcher from Medical Corps. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 18 publications receiving 428 citations. Previous affiliations of Tal Brosh-Nissimov include Sheba Medical Center & Ben-Gurion University of the Negev.
Papers
More filters
Journal ArticleDOI
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch,Erez N. Baruch,Ilan Youngster,Guy Ben-Betzalel,Rona Ortenberg,Adi Lahat,Lior H. Katz,Katerina Adler,Daniela Dick-Necula,Stephen P. Raskin,Stephen P. Raskin,Naamah Bloch,Daniil Rotin,Liat Anafi,Camila Avivi,Jenny Melnichenko,Yael Steinberg-Silman,Ronac Mamtani,Hagit Harati,Nethanel Asher,Ronnie Shapira-Frommer,Tal Brosh-Nissimov,Yael Eshet,Yael Eshet,Shira Ben-Simon,Oren Ziv,Abdul Wadud Khan,Moran Amit,Nadim J. Ajami,Iris Barshack,Iris Barshack,Jacob Schachter,Jacob Schachter,Jennifer A. Wargo,Omry Koren,Gal Markel,Gal Markel,Ben Boursi,Ben Boursi,Ben Boursi +39 more
TL;DR: Treatment with FMT was associated with favorable changes in immune cell infiltrates and gene expression profiles in both the gut lamina propria and the tumor microenvironment, which have implications for modulating the gut microbiota in cancer treatment.
Journal Article
Strychnine--a killer from the past.
Igor Makarovsky,Gal Markel,Azik Hoffman,Ophir Schein,Tal Brosh-Nissimov,Zeev Tashma,Tsvika Dushnitsky,Arik Eisenkraft +7 more
TL;DR: Though strychnine is lethal to humans, early aggressive treatment can be life saving, even following exposure to large doses as high as 3750 mg, and in view of the rise in global terrorism, it is important to recognize that stRYchnine may be utilized by terrorists to induce mass poisoning in urban populations by contamination of major food and water supplies.
Journal ArticleDOI
Evaluation of a benchtop HIV ultradeep pyrosequencing drug resistance assay in the clinical laboratory.
Boaz Avidor,Shirley Girshengorn,Natalia Matus,Hadass Talio,Svetlana Achsanov,Irene Zeldis,Ilana S. Fratty,Eugene Katchman,Tal Brosh-Nissimov,David Hassin,Danny Alon,Zvi Bentwich,Israel Yust,Sharon Amit,Relly Forer,Ina Vulih Shultsman,Dan Turner +16 more
TL;DR: The prototype assay performs at least as well as TruGene and has the advantage of detecting low-abundance drug resistance mutations undetected by TruGene, whose ease of use and lab-scale platform will likely facilitate its use in the clinical laboratory.
Journal ArticleDOI
Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017.
Ana Belkin,Zeala Gazit,Nathan Keller,Ronen Ben-Ami,Anat Wieder-Finesod,Ana Novikov,Galia Rahav,Tal Brosh-Nissimov +7 more
TL;DR: Phylogenetic analysis showed resemblance of C. auris to isolates from South Africa but not Israel, suggesting travel-associated infection, and infection occurred weeks later in another patient at the same hospital, suggesting prolonged environmental persistence.
Journal ArticleDOI
A novel swine model of ricin-induced acute respiratory distress syndrome.
Shahaf Katalan,Reut Falach,Amir Rosner,Michael Goldvaser,Tal Brosh-Nissimov,Ayana Dvir,Avi Mizrachi,Orr Goren,Barak Cohen,Yoav Gal,Anita Sapoznikov,Sharon Ehrlich,Tamar Sabo,Chanoch Kronman +13 more
TL;DR: The pig is established as a large animal model for the comprehensive study of the multifarious clinical manifestations of pulmonary ricinosis and its establishment should help in the pursuit of efficient medical countermeasures specifically tailored to deal with the respiratory deficiencies stemming from ricin-induced ARDS.